ArticleSensors (Basel, Switzerland)2024
The Optical Parameter Optimization for Brain Implant Alzheimer Sensor Using Phototherapy Angle and Wavelength Simulation (PAWS) Methodology.
Article in Sensors (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- SAR-Constrained Wireless Power Transfer Modeling for an Implantable Optical Neurostimulator Sensors.Sensors (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Photonic therapy is emerging as a promising method in neuroscience for addressing Alzheimer's disease (AD). This study uses computational simulations to investigate the impact of specific wavelengths emitted by photodiodes on the light absorption rates in brain tissue for brain implant sensors. Additionally, it presents a novel methodology that enhances light absorption via multi-parameter optimization. By adjusting the angle and wavelength of the incident light, the absorption rate was significantly enhanced using four photodiodes, each emitting at 660 nm with a power input of 3 mW. Notably, an incident angle of 20 degrees optimized light absorption and minimized thermal effects on brain tissue. The findings indicate that photodiodes within the near-infrared spectrum are suitable for low-temperature therapeutic applications in brain tissues, affirming the viability of non-invasive and safe photonic therapy. This research contributes foundational data for advancing brain implant photonic sensor design and therapeutic strategies. Furthermore, it establishes conditions for achieving high light absorption rates with minimal heat generation, identifying optimal parameters for efficient energy transfer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.